Agonist News and Research

RSS
Glucose-lowering drugs may reduce risk of developing epilepsy

Glucose-lowering drugs may reduce risk of developing epilepsy

Untreated restless legs syndrome may increase Parkinson's disease risk

Untreated restless legs syndrome may increase Parkinson's disease risk

Stopping GLP-1 drugs before pregnancy leads to more weight gain

Stopping GLP-1 drugs before pregnancy leads to more weight gain

Semaglutide helps older adults lose weight without immediate bone loss

Semaglutide helps older adults lose weight without immediate bone loss

GLP-1 discontinuation associated with more weight gain and pregnancy complications

GLP-1 discontinuation associated with more weight gain and pregnancy complications

Study finds GLP-1 drugs improve strength and reverse aging biology in mice

Study finds GLP-1 drugs improve strength and reverse aging biology in mice

Oral GLP-1 pill shows strong weight loss and blood sugar benefits in adults with diabetes

Oral GLP-1 pill shows strong weight loss and blood sugar benefits in adults with diabetes

Searches for “Ozempic face” surge as people look for filler-based solutions

Searches for “Ozempic face” surge as people look for filler-based solutions

Oral semaglutide delivers real-world drops in blood sugar and weight in diabetes trial

Oral semaglutide delivers real-world drops in blood sugar and weight in diabetes trial

Brain recordings reveal short-lived effects of tirzepatide on food cravings

Brain recordings reveal short-lived effects of tirzepatide on food cravings

Novel triple receptor agonist shows potent efficacy in lowering high triglycerides

Novel triple receptor agonist shows potent efficacy in lowering high triglycerides

GLP-1 drugs beat metformin for weight control in teens with type 2 diabetes

GLP-1 drugs beat metformin for weight control in teens with type 2 diabetes

Do GLP-1 drugs cause cancer? New review says no, may even protect

Do GLP-1 drugs cause cancer? New review says no, may even protect

New approach harnesses tumor's own machinery to produce immune-stimulating molecules

New approach harnesses tumor's own machinery to produce immune-stimulating molecules

Healthy lifestyle habits plus GLP-1 RA drugs can improve heart health of people with Type 2 diabetes

Healthy lifestyle habits plus GLP-1 RA drugs can improve heart health of people with Type 2 diabetes

Diabetes remission possible with GLP-1 drugs, Italian study confirms

Diabetes remission possible with GLP-1 drugs, Italian study confirms

Systematic analysis reveals psilocybin's impact on obsessive-compulsive behaviors

Systematic analysis reveals psilocybin's impact on obsessive-compulsive behaviors

Adequate support needed to address Canada's rising youth opioid use

Adequate support needed to address Canada's rising youth opioid use

Semaglutide protects the heart beyond weight loss, SELECT trial shows

Semaglutide protects the heart beyond weight loss, SELECT trial shows

New insight into TRPM3 heat sensor reveals how the body detects temperature

New insight into TRPM3 heat sensor reveals how the body detects temperature

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.